IL1B and atherosclerosis: Another study in animal models reported that pharmacological inhibition of NLRP3 inflammasome in TET2-deficient mice resulted in decreasing the inflammatory state, lowering IL-1β, and ameliorating atherosclerosis and heart failure [66].